¼¼°èÀÇ OTC ÀǾàǰ¿ë Çâ·á ½ÃÀå
Flavors in Over-the-Counter Pharmaceuticals
»óǰÄÚµå : 1758761
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,171,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,515,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ OTC ÀǾàǰ¿ë Çâ·á ½ÃÀåÀº 2030³â±îÁö 31¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 22¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ OTC ÀǾàǰ¿ë Çâ·á ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 5.7%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 31¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¹Ù´Ò¶ó Çâ·á´Â CAGR 7.1%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 8¾ï 1,410¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÃÊÄݸ´ & ÄÚÄÚ¾Æ Çâ·á ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 7.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 6¾ï 40¸¸ ´Þ·¯, Áß±¹Àº CAGR 9.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ OTC ÀǾàǰ¿ë Çâ·á ½ÃÀåÀº 2024³â¿¡ 6¾ï 40¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¾ï 3,010¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 9.3%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.7%¿Í 5.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ OTC ÀǾàǰ¿ë Çâ·á ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿Ö Çâ·á°¡ OTC ÀǾàǰ Á¦Á¦ÀÇ Áß½ÉÀÌ µÇ°í Àִ°¡?

ÀϹÝÀǾàǰ(OTC)¿¡¼­ Çâ·áÀÇ »ç¿ëÀº ÀÌÂ÷ÀûÀÎ Á¦Á¦ ¿ä¼Ò¿¡¼­ ƯÈ÷ ¼Ò¾Æ, ³ëÀÎ ¹× ¸¸¼ºÁúȯ ºÐ¾ß¿¡¼­ Á¦Ç° ¼ö¿ë¼ºÀ» °áÁ¤ÇÏ´Â Áß¿äÇÑ ¿ä¼Ò·Î º¯È­Çϰí ÀÖ½À´Ï´Ù. Çâ·á´Â ÇöÀç À¯È¿¼ººÐ(API)ÀÇ ¾´¸À, ¶µÀº¸À, È­ÇÐÀû ¸ÀÀ» ¸¶½ºÅ·Çϱâ À§ÇØ Àü·«ÀûÀ¸·Î »ç¿ëµÇ°í ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ȯÀÚÀÇ ¼øÀÀµµ¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. °æÀïÀÌ Ä¡¿­ÇÑ OTC ½ÃÀå¿¡¼­ Á¦Ç°ÀÇ ¸À°ú °ü´ÉÀû ¸Å·ÂÀº ºê·£µå Â÷º°È­, ¼ÒºñÀÚ Ãæ¼ºµµ, À籸¸Å¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ¿©°ÜÁö°í ÀÖÀ¸¸ç, ƯÈ÷ ½Ã·´Á¦, Ãò¾îºíÁ¦, ¿ëÇØÁ¦, Æ®·ÎÄ¡Á¦, ±¸°­ºØÇØÇʸ§¿¡¼­ ÀÌ·¯ÇÑ °æÇâÀÌ °­ÇÕ´Ï´Ù.

¿À´Ã³¯ ¼ÒºñÀÚµéÀº ±â´É¼º ½ÄǰÀ̳ª °Ç°­º¸Á¶½Äǰ°ú ¸¶Âù°¡Áö·Î ÀǾàǰµµ º¸´Ù Æí¾ÈÇÑ ¼Òºñ °æÇèÀ» Á¦°øÇÒ °ÍÀ» ±â´ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒºñÀÚ ÁÖµµ ¼ö¿ä·Î ÀÎÇØ Á¦¾à ºê·£µå´Â Ç¥ÁØÀûÀÎ ¹ÎÆ®³ª ü¸®¸¦ ³Ñ¾î ¸Á°í ¹ÙÁú, ¼®·ù »ý°­, º£¸® ¶óÀÓ°ú °°Àº À̱¹ÀûÀ̰í Ç»ÀüÀûÀÎ ¸ÀÀ» ޱ¸Çϰí Áö¿ªÀû ¹Ì°¢ ÃëÇâ°ú ¼ÒºñÀÚ µ¿Çâ¿¡ ¸ÂÃß¾î Çõ½ÅÀ» Ãß±¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °¨°¢ ¿ì¼±ÀÇ Á¢±Ù ¹æ½ÄÀº ƯÈ÷ °¨±â ¹× µ¶°¨, ¼ÒÈ­Á¦, ºñŸ¹Î, ±¸°­°ü¸® µî OTC Ä«Å×°í¸®¿¡¼­ Æ÷Àå, ºê·£µù, Á¦Ç° Æ÷Áö¼Å´× Àü·«¿¡µµ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

±â¼ú ¹× ±ÔÁ¤ÀÇ º¯È­´Â ¸ÀÀÇ ÅëÇÕÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

OTC ÀǾàǰÀÇ Çâ·á ¹èÇÕÀº Çâ·á ¸¶½ºÅ· ±â¼ú, ÀÎĸ½¶·¹ÀÌ¼Ç ¹× ¹æÃâ Á¦¾î ½Ã½ºÅÛÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ Á¤Á¦È­ÀÇ ¹°°áÀÌ ¹Ð·Á¿À°í ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·ÎÀÎĸ½¶·¹À̼Ç, »çÀÌŬ·Îµ¦½ºÆ®¸° º¹ÇÕÈ­, ÁöÁú ±â¹Ý ij¸®¾î¿Í °°Àº ±â¼úÀ» ÅëÇØ Çâ·á ¼ººÐÀÇ ¾ÈÁ¤¼ºÀ» ³ôÀ̰í, º¸Á¸ ±â°£À» ¿¬ÀåÇϸç, À¯È¿ ¼ººÐÀÇ ¼º´É°ú ¹æÃâÀ» µ¿±âÈ­ÇÏ´Â ¹æ½ÄÀ¸·Î Çâ·á ¼ººÐÀ» Àü´ÞÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ºÒÄèÇÑ °¨°¢À» È¿°úÀûÀ¸·Î ¸¶½ºÅ·ÇÏ´Â µ¿½Ã¿¡ Çâ·á°¡ ¿ø¾à°ú ºÎÀÛ¿ëÀ» ÀÏÀ¸Å°Áö ¾Êµµ·Ï º¸ÀåÇÕ´Ï´Ù.

±ÔÁ¦ Ãø¸é¿¡¼­ Çâ·á Á¦Á¶¾÷üµéÀº ÀÇ·á¿ë Á¦Á¦¿¡ »ç¿ëµÇ´Â ¼ººÐÀÇ ¾ÈÀü¼º°ú ¾Ë·¹¸£±â À¯¹ß °¡´É¼º¿¡ ´ëÇÑ °¨½Ã°¡ °­È­µÊ¿¡ µû¶ó ÀÌ¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¾î¸°ÀÌ¿ë Á¦Ç°À̳ª 'Ŭ¸° ¶óº§' ¶Ç´Â 'õ¿¬ °Ç°­ ¼Ö·ç¼Ç'À¸·Î ÆÇ¸ÅµÇ´Â Á¦Ç°¿¡¼­´Â õ¿¬, ºñGMO, ¹«¾Ë·¯Áö Çâ·á¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¾àÀü ±âÁØ, FDAÀÇ GRAS µî±Þ, Áö¿ª ÷°¡Á¦ ±ÔÁ¤ Áؼö, Çâ·á ¼±Åÿ¡ ¿µÇâÀ» ¹ÌÄ¡°í ¸¹Àº ½ÃÀå¿¡¼­ Àΰø Çâ·áÀÇ »ç¿ëÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ÀÇ ¿µÇâÀ¸·Î Çâ·á¾÷ü¿Í Á¦¾àȸ»ç´Â ¸À, ¾ÈÀü¼º ¹× ±ÔÁ¤ Áؼö »çÀÌÀÇ ±ÕÇüÀ» ¸ÂÃâ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ» °øµ¿ °³¹ßÇØ¾ß ÇÒ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù.

Ư¼ö Çâ·á ¼ö¿ä¸¦ ÁÖµµÇÏ´Â ÃÖÁ¾ ¿ëµµ Ä«Å×°í¸®´Â ¹«¾ùÀΰ¡?

ƯÈ÷ ¼±È£µµ°¡ Ä¡·á ¼øÀÀµµ¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â ƯÁ¤ Ä¡·á Ä«Å×°í¸®¿¡¼­ Çâ·á Çõ½Å¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±× ´ëÇ¥ÀûÀÎ ¿¹°¡ ¼Ò¾Æ¿ë ÀǾàǰÀ¸·Î, ¹Ì°¢ÀÇ ¼ö¿ë¼ºÀÌ º¹¿ë ¿ä¹ýÀ» ¿Ï·áÇÏ´Â µ¥ ¿µÇâÀ» ¹ÌÄ¡´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ±× °á°ú, ¾î¸°ÀÌ¿ë OTC ÀǾàǰÀº °úÀÏ ¸À ½Ã·´, ¹ßÆ÷¼º °ú¸³, Á©¸® Á¦Çü µîÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î ½ÄÀ̼¶À¯ º¸ÃæÁ¦, º¯ºñ¾à, Á¦»êÁ¦ µî °í·ÉÀÚ¸¦ À§ÇÑ Á¦Ç°µµ ¹Ì°¢ÀÌ µÐÈ­µÊ¿¡ µû¶ó ¼øÇÑ ¸ÀÀ̳ª ÁßÈ­ ¸ÀÀ» äÅÃÇÏ¿© µÞ¸ÀÀÌ ÁÁÁö ¾ÊÀº °ÍÀ» ÇÇÇϰí ÀÖ½À´Ï´Ù.

¼Òµ¶¿ë ¼¼Á¤¾×, °¡±Û¾×, ÀÎÈĽºÇÁ·¹ÀÌ µî ÇâÀ» ÷°¡ÇÑ ±¸°­ °ü¸® Á¦Ç°µµ Áß¿äÇÑ ºÐ¾ßÀÔ´Ï´Ù. ÀÌ ºÐ¾ß¿¡¼­ ÇâÀº ´Ü¼øÈ÷ ÀÔ¸ÀÀ» ÁÁ°Ô ÇÏ´Â °Í»Ó¸¸ ¾Æ´Ï¶ó, Á¦Ç°ÀÇ È¿´ÉÀ» ÀνÄÇÏ°Ô ÇÏ´Â ÁøÁ¤, ÁøÁ¤, ³Ã°¢ ¶Ç´Â »óÄèÇÏ°Ô ÇÏ´Â ÀÔ¸ÀÀ» Á¦°øÇÕ´Ï´Ù. ¼ö¸é º¸Á¶Á¦, ¿¡³ÊÁö °­È­Á¦, ¸é¿ª·Â ÁõÁø º¸ÃæÁ¦ µî ±â´É¼º OTC Ä«Å×°í¸®µµ ½Äǰ¿¡ Àͼ÷ÇÑ ¼ÒºñÀÚ °æÇèÀ» ¸ð¹æÇϱâ À§ÇØ ÇâÀ» Àü¸é¿¡ ³»¼¼¿î Æ÷¹Ä·¯¸¦ äÅÃÇÏ´Â Ãß¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇâÀÇ Àû¿ëÀº ´Ü¼øÈ÷ ¸¶½ºÅ·¿¡ ±×Ä¡Áö ¾Ê°í ½Å¼±ÇÔ, ¾ÈÁ¤°¨, Àڱذú °°Àº ±â´ÉÀû ÀÌÁ¡À» Æ÷ÇÔÇÏ¸ç °æÇèÀû °¡Ä¡¸¦ ´õÇϰí ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀå ºÎ¹®ÀÇ ¼ºÀåÀ» Áö¿øÇÏ´Â ÁÖ¿ä ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

OTC ÀǾàǰÀÇ Çâ·á ½ÃÀåÀÇ ¼ºÀåÀº Á¦Ç° Çõ½Å, ȯÀÚ Áß½É Ã³¹æ Àü·«, ¼ÒºñÀÚ ±â´ëÄ¡ÀÇ ÁøÈ­¿¡ ±â¹ÝÇÑ ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ÀǾàǰ°ú À£´Ï½º Á¦Ç° °£ÀÇ Áߺ¹ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¼±È£µµ¿Í »ç¿ëÀÚ °æÇèÀÌ ½ÃÀåÀÇ ¼º°øÀ» Á¿ìÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¼ÒºñÀÚµéÀÌ º¸´Ù Àç¹ÌÀÖ°í ¶óÀÌÇÁ½ºÅ¸ÀÏ¿¡ ¸Â´Â OTC ¼Ö·ç¼ÇÀ» ¿øÇÔ¿¡ µû¶ó °¢ ºê·£µå´Â °úÀÚ, À½·á, ±â´É¼º ½º³¼À» ¸ð¹æÇÑ ÇâÀÌ Ã·°¡µÈ Æ÷¸ËÀ¸·Î ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.

¼Ò¾Æ ¹× ³ëÀοë Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó È¿´ÉÀ» ¼Õ»ó½ÃŰÁö ¾ÊÀ¸¸é¼­ Ä¡·á ¼øÀÀµµ¸¦ º¸ÀåÇϱâ À§ÇØ °í±Þ Çâ·á ¸¶½ºÅ· ±â¼úÀ» »ç¿ëÇØ¾ß ÇÏ´Â »óȲÀÌ µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ Ãò¾îºí Á¤Á¦, ºÐ»ê¼º ºÐ¸», ¼Ó¿ë¼º Çʸ§ÀÌ Æí¸®ÇÑ Àü´Þ ½Ã½ºÅÛÀ¸·Î ±Þ¼ºÀåÇϸ鼭 ´Ù¾çÇÑ ¸ÂÃãÇü ÇâÀ» ÅëÇÕÇÒ ¼ö ÀÖ´Â ±âȸ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Áö¿ªÀû ¸À¿¡ ´ëÇÑ ¼±È£µµ¿Í ¹®È­Àû ÃëÇâ µ¿Çâµµ Á¦Ç° °³¹ßÀ» Çü¼ºÇϰí ÀÖÀ¸¸ç, ƯÁ¤ °èÃþÀ» ²ø¾îµéÀ̱â À§ÇØ Áö¿ª ÇÑÁ¤ ¸ÀÀÇ º¯ÇüÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ãµ¿¬ Çâ·á¿Í ¾Ë·¹¸£°ÕÀÌ ¾ø´Â Çâ·á È­ÇÕ¹°ÀÇ ±â¼ú Çõ½ÅÀº ±ÔÁ¤ Áؼö ¹× °Ç°­ ÁöÇâÀû Á¦Ç° ¶óÀÎÀÇ ÆøÀ» ³ÐÈ÷°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÁøÈ­ÇÏ´Â OTC ÀǾàǰ »ê¾÷¿¡¼­ Çâ·á Á¦Á¦°¡ °è¼ÓÇØ¼­ Áß¿äÇÑ ¼ºÀå µ¿·ÂÀÌ µÉ °ÍÀÓÀ» º¸ÀåÇÕ´Ï´Ù.

ºÎ¹®

Çâ·á À¯Çü(¹Ù´Ò¶ó Çâ·á, ÃÊÄݸ´ & ÄÚÄÚ¾Æ Çâ·á, °úÀÏ Çâ·á, Å©¸² & ¿ìÀ¯ Çâ·á, ½ÃÆ®·¯½º & ¹ÎÆ® Çâ·á, ±âŸ Çâ·á)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Flavors in Over-the-Counter Pharmaceuticals Market to Reach US$3.1 Billion by 2030

The global market for Flavors in Over-the-Counter Pharmaceuticals estimated at US$2.2 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Vanilla Flavor, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$814.1 Million by the end of the analysis period. Growth in the Chocolate & Cocoa Flavor segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$600.4 Million While China is Forecast to Grow at 9.3% CAGR

The Flavors in Over-the-Counter Pharmaceuticals market in the U.S. is estimated at US$600.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$630.1 Million by the year 2030 trailing a CAGR of 9.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Flavors in Over-the-Counter Pharmaceuticals Market - Key Trends & Drivers Summarized

Why Are Flavors Becoming Central to OTC Pharmaceutical Formulations?

The use of flavors in over-the-counter (OTC) pharmaceuticals has transitioned from a secondary formulation element to a critical determinant of product acceptance, especially in pediatric, geriatric, and chronic care segments. Flavors are now strategically used to mask the bitterness, astringency, or chemical taste of active pharmaceutical ingredients (APIs), thereby improving patient compliance. In an increasingly competitive OTC market, product palatability and sensory appeal are considered essential to brand differentiation, consumer loyalty, and repeat purchases-particularly for syrups, chewables, dissolvables, lozenges, and mouth-dissolving films.

Consumers today expect medicinal products to deliver a more pleasant consumption experience, akin to functional foods or nutraceuticals. This consumer-driven demand is compelling pharmaceutical brands to innovate beyond standard mint or cherry, exploring exotic and fusion flavors such as mango-basil, pomegranate-ginger, or berry-lime to align with regional taste preferences and consumer trends. This sensory-first approach is also influencing packaging, branding, and product positioning strategies, especially for OTC categories like cold & flu, digestive aids, vitamins, and oral care.

How Are Technological and Regulatory Changes Shaping Flavor Integration?

Flavor formulation in OTC pharmaceuticals is undergoing a wave of sophistication, aided by advances in flavor masking technologies, encapsulation, and controlled release systems. Techniques such as microencapsulation, cyclodextrin complexation, and lipid-based carriers are enabling the delivery of flavor components in ways that enhance stability, extend shelf life, and synchronize release with active ingredient performance. These systems ensure that flavors do not interact adversely with APIs while still masking unpleasant sensory notes effectively.

From a regulatory perspective, flavor manufacturers are adapting to increased scrutiny surrounding the safety and allergenicity of ingredients used in medical formulations. There is a growing preference for natural, non-GMO, and allergen-free flavoring agents, particularly in products targeting children or those marketed as “clean label” or “natural health solutions.” Compliance with pharmacopeial standards, FDA GRAS status, and regional additive regulations is shaping the choice of flavoring materials and limiting the use of artificial flavoring substances in many markets. This regulatory influence is pushing flavor houses and pharmaceutical companies to co-develop solutions that balance taste, safety, and compliance.

Which End-Use Categories Are Driving Demand for Specialty Flavoring?

Certain therapeutic categories are showing heightened demand for flavor innovation, especially where palatability has a direct impact on therapeutic adherence. Pediatric medicines top the list, where taste acceptance often determines whether a child completes a dosage regimen. As a result, children’s OTC lines are expanding into fruit-flavored syrups, effervescent granules, and gummy formulations. Similarly, geriatric products-including fiber supplements, laxatives, and antacids-are adopting mellow or neutralizing flavors to suit reduced taste sensitivity and avoid aftertaste.

Flavored oral care solutions such as antiseptic rinses, lozenges, and sore throat sprays are another significant segment. Here, flavors do more than improve palatability-they provide a soothing, cooling, or refreshing mouthfeel that enhances the perceived effectiveness of the product. Functional OTC categories such as sleep aids, energy boosters, and immunity-boosting supplements are also increasingly adopting flavor-forward formulations to mimic consumer experiences familiar from food and beverage products. These flavor applications extend beyond masking to include functional benefits such as freshness, calmness, or stimulation-thus adding experiential value.

What Are the Primary Drivers Supporting Growth in This Market Segment?

The growth in the flavors in over-the-counter pharmaceuticals market is driven by several factors rooted in product innovation, patient-centric formulation strategies, and evolving consumer expectations. One major driver is the increasing overlap between pharmaceuticals and wellness products, where taste and user experience significantly influence market success. As consumers seek more enjoyable, lifestyle-compatible OTC solutions, brands are responding with flavored formats that mimic confections, beverages, or functional snacks.

Rising demand for pediatric and geriatric formulations is compelling the use of advanced flavor masking techniques to ensure therapeutic adherence without compromising efficacy. Additionally, the surge in chewable tablets, dispersible powders, and fast-melt films as convenient delivery systems is expanding opportunities for integrating diverse and customized flavors. Regional flavor preferences and cultural taste trends are also shaping product development, encouraging localized flavor variants to capture specific demographics. Furthermore, innovation in natural and allergen-free flavor compounds is broadening the scope for compliant and health-conscious product lines. Together, these trends are ensuring that flavor formulation remains a key growth lever in the evolving OTC pharmaceuticals landscape.

SCOPE OF STUDY:

The report analyzes the Flavors in Over-the-Counter Pharmaceuticals market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Flavors Type (Vanilla Flavor, Chocolate & Cocoa Flavor, Fruit Flavor , Cream & Milk Flavor, Citrus & Mint Flavor, Other Flavors)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â